Home
About
- Overview
- Team
- Investors
Science
Pipeline
Partners
News & Events
Contact
Menu Menu

ALS Drug NRG5051 Targets Mitochondrial Pore to Protect Neurons

9 September 2026

Longevity Pulse

https://www.nrgtherapeutics.com/wp-content/uploads/2026/09/LP_090926.jpg 720 1280 Webadm https://www.nrgtherapeutics.com/wp-content/uploads/2026/07/NRG_Logo.png Webadm2026-09-09 10:05:482026-09-14 10:06:34ALS Drug NRG5051 Targets Mitochondrial Pore to Protect Neurons

© NRG Therapeutics

Terms & Conditions
Privacy Policy

New ALS drug data reveal a mitochondrial fix

My Name’5 Doddie Foundation’s Discovery Network Showcase 2026